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It has long been recognized that energy metabolism is linked to the production of reactive oxygen species
(ROS) and critical enzymes allied to metabolic pathways can be affected by redox reactions. This interplay
between energy metabolism and ROS becomes most apparent during the aging process and in the onset
and progression of many age-related diseases (i.e. diabetes, metabolic syndrome, atherosclerosis, neu-
rodegenerative diseases). As such, the capacity to identify metabolic pathways involved in ROS forma-
tion, as well as speciﬁc targets and oxidative modiﬁcations is crucial to our understanding of the mo-
lecular basis of age-related diseases and for the design of novel therapeutic strategies.
Herein we review oxidant formation associated with the cell's energetic metabolism, key antioxidants
involved in ROS detoxiﬁcation, and the principal targets of oxidant species in metabolic routes and
discuss their relevance in cell signaling and age-related diseases.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).B.V. This is an open access article u
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Energy metabolism, the process of generating energy (ATP)
from nutrients, comprises a series of reactions in which biomole-
cules are oxidized to simpler molecules and the energy released in
these thermodynamically favorable processes is harnessed to
phosphorylate ADP. Redox reactions that involve the transfer of
electrons from reduced organic molecules, to acceptor molecules
such as NADþ , NADPþ or oxygen, are key components of these
pathways. Reactive oxygen species (ROS) such as superoxide anion
radical (O2∙) and hydrogen peroxide (H2O2) are products or by-
products of metabolic redox reactions. These species can partici-
pate in cell signaling events and their formation can affect the cell
and tissue structure and function.
Neither O2∙ nor H2O2 are particularly toxic in vivo, since these
species are not very reactive [1] and can be removed by a battery
of antioxidant enzymes that catalyze their reduction or dismuta-
tion. However, the reaction of superoxide with the intercellular
messenger nitric oxide (∙NO) leads to the formation of the reactive
oxidant peroxynitrite and other oxidant species collectively known
as reactive nitrogen species (RNS). In turn H2O2 interaction with
metals such as iron, promotes the formation of the potent oxidants
hydroxyl radical (∙OH) and oxo-metal complexes. These highly
oxidant species are responsible of most of the oxidative damage
observed in pathological conditions. Among the targets of reactive
oxidant species, we ﬁnd enzymes proteins and lipids from cata-
bolic pathways involved in ATP synthesis, and whose inhibition
may be involved in cell signaling events or organelle dysfunction.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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the cell's energetic metabolism, key antioxidants involved in ROS
detoxiﬁcation, and the principal targets of oxidant species in me-
tabolic routes and discuss their relevance in cell signaling and age-
related diseases.2. Oxidant formation during mitochondrial ATP synthesis:
tricarboxylic acid cycle and electron transport chain
Mitochondrial ROS and RNS production has been reported ex-
tensively in the literature [2–7] and the electron transport chain
(ETC) has been acknowledged for a long time as one of the main
intracellular sites of O2∙ formation [8,9]. In addition, modulation
of oxidant formation by mitochondria can limit the initiation and
progression of diseases whose pathogenesis involves mitochon-
drial dysfunction [10,11], highlighting the relevance of these
processes.
Mitochondria are primary sites of intracellular formation and
reactions of ROS and RNS (Fig. 1). Depending on formation rates
and steady-state levels, these short-lived reactive species con-
tribute to signaling events and can mediate mitochondrial dys-
function in pathology through oxidative modiﬁcations of mi-
tochondrial molecular components.
2.1. Superoxide and hydrogen peroxide formation by complexes of
the Electron Transport Chain and Tricarboxylic Acid Cycle
The addition of a single electron to oxygen (O2) leads to the
formation of O2∙ . During catabolism O2∙ is formed mostly as aFig. 1. Oxidant formation and main oxidant targets during mitochondrial ATP synthesis.
mitochondrial electron transport chain Complex I and Complex III; ﬂavin dehydrogenase
GPDH), acyl CoA dehydrogenase (ACAD) and electron transfer ﬂavoprotein (ETF). The tra
oxidant formation (e.g., hydrogen peroxide, hydroxyl radical, peroxynitrite) by dismutat
details). The main mitochondrial targets of the different oxidant species (highlighted b
cytochrome c (Cyt c) and Complexes I, IV and IV of the respiratory chain (the mechan
interpretation of the references to color in this ﬁgure legend, the reader is referred to tbyproduct of the ETC in the mitochondria where, at physiological
O2 levels, 0.1-2% of total O2 is converted to O2∙ [12]. Indeed, O2∙
is the principal ROS formed by the mitochondrial ETC. The level
and rate of mitochondrial production of this radical depends on
the tissue, the substrates metabolized, and the site of the mi-
tochondrial electron transfer chain involved in its formation
[13,14]. Mitochondrial O2∙ is formed in the sites where mono-
electronic reduction of O2 is thermodynamically and kinetically
feasible (reviewed in [12,15]). These sites are found in electron
transport chain Complexes I and III.
Complex I (NADH–ubiquinone oxidoreductase), which con-
stitutes the entry point for electrons from NADH, is a complex
structure comprising 45 polypeptides, a ﬂavin mononucleotide
(FMN) cofactor and seven iron–sulfur (FeS) centers. Complex I
produces O2∙ by two mechanisms. Firstly, when matrix NADH/
NADþ ratio is high electron transfer from the reduced FMN co-
factor forms O2∙ . This mechanism involves the ubiquinone
(Q) binding site of Complex I, therefore rotenone that blocks Q
binding and maximizes FMN and FeS center reduction, increases
H2O2 release from mitochondria [14]. Superoxide can also be
formed during reverse electron transport (RET) from reduced
coenzyme Q (CoQH2) to Complex I [15]. This mechanism, pre-
dominates at high transmembrane potentials when forward elec-
tron ﬂux from CoQH2 to cytochrome c oxidase is hindered and
electrons are forced from CoQH2 to Complex I [15], and is therefore
inhibited by rotenone. RET is a relevant source of O2∙ in brain
[14], particularly in neurodegenerative diseases such as Parkinson
[16]. Recent reports, using a metabolomic approach, show RET is
also responsible of much of O2∙ formation during ischemia/re-
perfusion [17] when succinate is accumulated during hypoxia andMain sites of oxidant formation in mitochondria (highlighted by a red star) include
s, α-ketoglutarate dehydrogenase (α-KGDH), α-glycerophosphate dehydrogenase (α-
nsfer of electrons to oxygen generates superoxide radical which leads to secondary
ion, reaction with metals or by reaction with nitric oxide respectively (see text for
y a yellow star) include aconitase (Aco), succinate dehydrogenase (SDH), α-KGDH,
isms of inactivation and functional consequences are discussed in the text). (For
he web version of this article.)
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It is now known that a large proportion of the mitochondrial
complexes are arranged in supramolecular assemblies called su-
percomplexes or respirosomes. In addition to conferring kinetic
advantages through substrate channeling, supercomplexes are
required for the stability and assembly of Complex I. Super-
complex formation also prevents excessive ROS formation from
the respiratory chain, in fact disruption of supercomplex I-III in-
creases ROS formation by Complex I [18–20].
Complex III (ubiquinol–cytochrome c oxidoreductase) accepts
reducing equivalents formed in Complex I and II. Complex III
contains 11 polypeptides, 3 hemes and a FeS center and interacts
with coenzyme Q (CoQ) during the Q cycle. The reaction of O2 with
ubisemiquinone (CoQH∙) leads to the formation of O2∙ in both
sides of the inner mitochondrial membrane [21]. Therefore con-
ditions which enhance the reduction and stabilization of the
CoQH∙ will favor O2∙ formation by Complex III (e.g. electron
transport inhibition with antimycin A) [12].
The anionic character of O2∙ limits its diffusion across mem-
branes conﬁning the reactions of this radical to the mitochondria.
The main reactions of O2∙ in mitochondria include: (1) the
spontaneous or superoxide dismutase (SOD)-catalyzed dismuta-
tion to H2O2 and O2 (k¼2109 M–1 s–1); (2) direct reaction with
FeS centers leading to their disruption (e.g. mitochondrial aconi-
tase FeS center k¼107 M–1 s–1) [22] or (3) reaction with ∙NO to
yield peroxynitrite (k¼4.3-20109 M–1 s–1) [23,30,31].
Hydrogen peroxide is a non-radical diffusible oxidant that be-
comes toxic to most cells types at concentrations over 10 mM
[15,24,25]. It is a weak oxidant and reductant, and its reactivity
with enzymes and proteins relies in its capacity to oxidize labile
thiols and metal containing molecules [26,27]. Oxidation of thiols
in cysteine residues is responsible of most of H2O2 signaling inside
the cell [26,27] and reactions with metal centers are part of the
catalytic mechanism of heme dependent peroxidases. However,
the reactions with metal centers can also be cytotoxic mainly due
to the formation of highly oxidative species such as ∙OH [28].
Although mitochondrial oxidant formation is primarily as-
cribed to the respiratory complexes, other mitochondrial enzymes
in particular ﬂavoenzymes, can also produce O2∙ and H2O2 as
byproducts [14]. The Tricarboxylic Acid Cycle (TCA) enzyme α-
ketoglutarate dehydrogenase (α-KGDH) and glycerophosphate
dehydrogenase (α-GPDH) complexes are considered relevant
sources of ROS in brain mitochondria, particularly under condi-
tions of high mitochondrial membrane potential [13,29].
2.2. Peroxynitrite formation in mitochondria
Peroxynitrite anion (ONOO–) is a strong oxidant formed in the
fast reaction between the signaling radical ∙NO and O2∙– [30–31].
Peroxynitrite anion is a rather stable molecule, able to react with
Lewis acids, such as CO2 and electrophilic transition metal centers,
yielding a variety of potent oxidants [32] such as nitrogen dioxide
(∙NO2), carbonate radical (CO3∙–) [33] and oxo-metal complexes [34].
Peroxynitrous acid (pKa¼6.8, ONOOH) in turn can undergo a pro-
ton-catalyzed homolysis to ∙NO2 and ∙OH in 30% yields [35–37].
Nitric oxide is a small amphipathic molecule and modestly
reactive radical that is freely permeable through cellular mem-
branes [38–39]. It is produced by the aerobic oxidation of L-argi-
nine in a reaction catalyzed by nitric oxide synthases (NOS, i.e.
constitutive endothelial and neuronal as well as inducible iso-
forms) [40] and can freely diffuse into the mitochondria. Besides,
several reports support that a mitochondrial NOS can also con-
tribute to mitochondrial ∙NO formation (reviewed in [41]).
The direct effects of ∙NO in mitochondria are mainly due to its
capacity to compete with oxygen for the interaction with the bi-
nuclear (Cuþ-Fe2þ) center of cytochrome c oxidase, modulating O2consumption, ATP and O2∙ formation (see below). However, in-
creases in O2∙ concentrations such as those observed in patholo-
gical conditions will shift the reactivity of ∙NO towards O2∙ , be-
cause the reaction becomes kinetically favored, leading to perox-
ynitrite formation [6,23]. Peroxynitrite-derived radical species and
oxo-metal complexes are involved in oxidation, peroxidation and
nitration reactions with mitochondrial components [32,42–47].
2.3. Lipid derived electrophiles formed in mitochondria
In the last years it has been recognized that lipid derived re-
active species can be formed in mitochondria and their reactions
with mitochondrial components result in mitochondrial dysfunc-
tion or have a physiological role modulating cell function [48–50].
Nitric oxide and ∙NO-derived species (NOx) lead to the forma-
tion of a wide variety of oxidized and nitrated products with
biologically and physiologically relevant properties [51–54].
Among these products, nitroalkenes have been characterized and
quantiﬁed in plasma of healthy and hypercholesterolemic patients
as well as in red blood cell membranes [55,56]. The alkenyl nitro
conﬁguration of nitroalkenes is responsible of the electrophilic
reactivity of the β-carbon adjacent to the nitro-bonded carbon.
Nitroalkenes can participate in reversible Michael addition reac-
tions with nucleophiles (i.e. cysteine or histidine residues in pro-
teins) [57,58] forming covalent, thiol reversible post-translational
modiﬁcations that may impact on protein structure, function and
subcellular distribution [58]. These modiﬁcations are now con-
sidered to transduce redox- and ∙NO-dependent cell signaling in a
variety of pathways. The reported concentrations ﬂuctuate from
nanomolar [59] to low micromolar concentrations [55], all of them
capable of exerting biological actions [60–61]. For example, it has
been reported that conjugated linoleic acid (CLA) is a preferential
target of nitrating species in mitochondria leading to the forma-
tion of nitroalkenes [50,62]. There are also reports that under is-
chemic preconditioning conditions, mitochondrial nitro-oleic
(NO2-OA) and nitro-linoleic (NO2-LA) acids are formed reaching
concentrations around 1 mM [50]. Nitroalkene formation can in-
crease in pathological conditions such as ischemia, were ROS and
RNS formation increase [50,62]. Several mitochondrial targets for
electrophiles can be found in mitochondria and the reactions of
these compounds with respiratory chain components and un-
coupling proteins have been postulated to modulate ATP and ROS
production, O2 consumption, matrix metabolic enzymes, and
apoptotic machinery and to exert cytoprotective actions in settings
of mitochondrial dysfunction [50,62].
In addition, mitochondrial polyunsaturated fatty acids are sus-
ceptible to lipoperoxidation promoted by ∙OH. The lipid peroxida-
tion products are α,β unsaturated aldehydes, such as 4-hydroxy-
trans-2,3-nonenal and 4-oxo-trans-2,3-nonenal. These products
covalently modify side chains of histidine, cysteine and lysine re-
sidues, producing free carbonyls attached to proteins. Increased
protein carbonylation is observed in diet-induced obese mice adi-
pose tissue, in obese human subcutaneous adipose tissue and in
cultured adipocytes treated with TNF-α. In the latter, approximately
one third of the mitochondrial proteins were carbonylated; in par-
ticular mitochondrial Complex I appears as a relevant target, lead-
ing to a decrease activity and increase ROS formation [63,64].3. Oxidant formation in fatty acid catabolism
3.1. Superoxide and hydrogen peroxide formation during mitochon-
drial fatty acid β-oxidation
Fatty acid metabolism is one of the principal sources of energy
for skeletal and cardiac muscle and is a very active route in the
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of short (oC8), medium (C8–C12) and long chain (C14–C20) fatty
acids to acetyl-CoA and the energy released in this processes is
used for ATP generation by oxidative phosphorylation [65]. Fatty
acids are activated to acyl-CoA by acyl-CoA synthetases [66] in the
outer mitochondrial membrane and β-oxidation, proceeds
through 4 steps: (a) oxidation, (b) hydration, (c) a second oxida-
tion and (d) thiolytic cleavage, releasing acetyl-CoA and an acyl-
CoA two carbons shorter than the original molecule.
Acyl-CoA dehydrogenases (ACAD) are ﬂavoproteins that cata-
lyze the ﬁrst step of mitochondrial β-oxidation, the oxidation of
acyl-CoA to trans-2-enoyl-CoA leading to the reduction of the FAD
prosthetic group in the active site of the enzyme which is then
reoxidized by the electron transfer ﬂavoprotein (ETF) [67]. Finally,
electrons ﬂow to ubiquinone through the electron transferring
ﬂavoprotein- ubiquinone oxidoreductase (ETF-QOR).
Five different enzymes of the ACAD family with different chain-
length speciﬁcity catalyze the oxidation of acyl-CoA: short-chain
acyl-CoA dehydrogenase (SCAD, oC8) medium chain acyl-CoA
dehydrogenase (MCAD, C4–C12), long chain acyl-CoA dehy-
drogenase (LCAD, C8–C20), very long chain acyl-CoA dehy-
drogenases 1 and 2 (VLCAD1 and VLCAD2, C12–C24) [68,69].
Mitochondrial β-oxidation of fatty acids is associated with an
increase in O2∙ and H2O2 formation [14,70], that is not only due
to univalent oxygen reduction by the ETC [71]. In fact, VLCAD
[72,73] and ETF [74] appear as additional sources of O2∙ forma-
tion during fatty acid catabolism (Figs. 1 and 3). ETF-QOR has also
been suggested as a plausible site of O2∙ formation [75] in this
setting but requires further conﬁrmation.
Very long chain acyl-CoA dehydrogenase plays a relevant role
in the catabolism of long-chain fatty acids in human tissues cat-
alyzing the major part of palmitoyl-CoA dehydrogenation [76]. The
levels of this enzyme are increased in the liver of mice under high
fat diet and have been shown to contribute to the increase-in
oxidative stress in the tissue in these conditions [73]. Further
studies with recombinant puriﬁed VLCAD demonstrated that the
enzyme possesses oxidase activity, and produces H2O2 as a by-
product of palmitoyl-CoA oxidation reactions [72]. Enzymatic ac-
tivity of VLCAD is regulated by phosphorylation of Ser586 by
protein kinase A (PKA) in ﬁbroblasts and suppression of this
posttranslational modiﬁcation inhibits dehydrogenase enzyme
activity and promotes ROS formation [76].
Studies with recombinant ETF have shown that this ﬂavopro-
tein produces O2∙ and H2O2 upon reduction by its substrate
MCAD [74]. As in most ﬂavoproteins the reactivity of ETF with
oxygen is dictated by the redox chemistry of the FAD cofactor that
is heavily inﬂuenced by the protein environment and by solvent
accessibility [77] The semiquinone radical (FADH∙) is responsible
of the reduction of oxygen to O2∙ and H2O2. This radical specie is
destabilized when ETF is tightly associated with its substrate
MCAD and mutations impairing this association favor ROS for-
mation [74].
Reactive oxygen species formation due to fatty acid oxidation
might be involved in the pathogenesis of nonalcoholic fatty liver
disease (NAFLD), the most common liver disorder worldwide.
NAFLD includes several diseases characterized by hepatic steatosis,
an excess of fat in the liver, in individuals who do not consume
signiﬁcant amounts of alcohol [78]. Hepatic steatosis can evolve to
steatohepatitis (NASH) and ROS have been proposed to mediate
hepatocyte damage and inﬂammation [79].
A role for fatty acid-derived ROS in cancer progression has been
recently postulated as well [80]. In hypoxic conditions HIF-1
suppression of MCAD and LCAD expression decreases fatty acid
oxidation and ROS formation, promoting cell proliferation of liver
cancer cell lines. Analysis of human liver cancer samples showed
that decreases in LCAD protein levels are associated with mortality[80], underscoring the relevance of fatty acid oxidation suppres-
sion in the progression of the disease.
Another setting were oxidant formation due to increased fatty
acid catabolism might become relevant is cell senescence, a cel-
lular state characterized by proliferation-arrest, activation of the
DNA damage response, changes in morphology, increase in lyso-
somal enzymes (such as β-galactosidase) and increase in reactive
oxygen species formation. Both NADPH oxidases (Nox1 and Nox4)
[81,82] and mitochondria [83] have been postulated as plausible
sources of oxidants in oncogenic Ras-induced senescence. In a
recent report, we observed a relevant increase in mitochondrial
fatty acid β oxidation and fatty acid dependent O2 consumption, in
human ﬁbroblasts undergoing oncogenic Ras-induced senescence
[84] that might be responsible for the increase in mitochondrial
oxidant formation [83].
3.2. Peroxisomal hydrogen peroxide formation by acyl-CoA oxidases
Peroxisomes contain many enzymes involved in lipid metabo-
lism that participate in the utilization of fatty acids as a source of
energy. Peroxisomes are involved in the β-oxidation of long chain,
very long chain fatty acids and branched fatty acids [65]. Fatty
acids are activated to acyl-CoA by acyl-CoA synthetases [66] in the
membrane of the peroxisome. Similar to mitochondrial oxidation,
peroxisomal β-oxidation, proceeds through oxidation, hydration, a
second oxidation and thiolytic cleavage reactions.
Acyl-CoA oxidases (ACOX) catalyze the ﬁrst and rate limiting
step in peroxisomal β-oxidation of fatty acids: The oxidation of
acyl-CoA to trans-2-enoyl-CoA, where O2 is the electron acceptor
of the reaction producing H2O2 [85].
In human liver peroxisomes, we can ﬁnd acyl-CoA oxidases
with different speciﬁcities, ACOX1, that oxidizes the CoA esters of
straight chain fatty acids and prostaglandins and ACOX2, which
oxidizes CoA esters of branched-chain fatty acids and bile acids
[86]. Acyl-CoA oxidases contain a FAD prosthetic group non-
covalently bound to the active site of the enzyme [87]. The ﬂavin
moiety of the cofactor is responsible of the two- electron reduction
of O2 to H2O2 [68].
Acyl-CoA oxidase expression is regulated by peroxisome pro-
liferator activated receptor alpha (PPARα) a ligand-activated
transcription factor member of the nuclear-hormone receptor [88],
abundant in liver, heart, brown adipose tissue, kidney, small and
large intestine [89]. Upon activation by ligand binding PPARα
promotes the transcription of several genes involved in fatty acid
catabolism, including peroxisomal fatty acid β-oxidation enzymes,
(e.g. ACOX1, bifunctional enzyme enoyl-CoA hydratase/L-3-hy-
droxyacyl-CoA dehydrogenase, and ketoacyl-CoA thiolase) [88],
mitochondrial fatty acid β-oxidation enzymes, and microsomal ω-
oxidation CYP4A enzymes (see [90] for a review on PPARα reg-
ulation and ligands). In mice, exposure to synthetic PPAR ligands,
such as the hipolipidemic drug rosiglitazone, results in an increase
in H2O2 production in the liver leading to DNA oxidation [91,92],
and has been proposed to play a role in the development of liver
tumors induced by these non-genotoxic compounds [93].4. Oxidant formation during purine catabolism
Xanthine oxidoreductase (XOR) is a molybdoﬂavin containing
protein that catalyzes the rate-limiting and terminal steps of
purine degradation in humans, the oxidation of hypoxanthine to
xanthine and ﬁnally to uric acid [94]. Intracellularly, the primary
reaction catalyzed by this enzyme is the reduction of NADþ to
NADH by the xanthine dehydrogenase (XDH) form. Upon the re-
versible oxidation of critical cysteine residues or limited proteo-
lysis, XDH is converted to xanthine oxidase (XO), which utilizes O2
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of O2∙ and H2O2 rather than NADH [94,95]. XDH also presents
partial oxidase activity [94,95], thus the conversion to XO is not
always necessary for oxidant formation. Many reports in both
animal models and clinical studies suggest a key role for XOR in
pathophysiology, being inhibition of XOR beneﬁcial in different
vascular inﬂammatory processes [96,97].
Circulating XO levels are elevated in several pathological states
(e.g. obesity, sickle cell anemia, and heart failure) [96–99], where
reactive species formed by this enzyme as well as NOX and mi-
tochondria contribute to the development of the disease [100]. In
the endothelium, local concentrations of XO are increased by im-
mobilization through the interactions of the enzyme with nega-
tively charged glycosaminoglycan (GAGs) in the vessel walls [101].
Immobilization, alters the afﬁnity of XO for xanthine at the mo-
lybdenum site and affects XO kinetics leading to an increase in the
Km and Ki for substrates and products respectively, when com-
pared to the soluble enzyme [101]. In healthy humans, plasma
concentrations of xanthine plus hypoxanthine are in the low mi-
cromolar range (2 mM); under these conditions immobilized XO
has reduced enzymatic activity (Km21 mM for xanthine) [101].
However, in pathological conditions plasma xanthine plus hy-
poxanthine concentrations can rise to 20–100 mM, a range sufﬁ-
cient to reach and exceed half-maximal activity for the im-
mobilized enzyme. For example, purine concentrations are ele-
vated under ischemic conditions where ATP catabolism is in-
creased, enhancing the formation of ROS by XO in the vascular
compartment [96,102,103]. The increase in O2∙ limits the bioa-
vailability of ∙NO leading to the formation of peroxynitrite which
potentiates oxidative inﬂammatory injury [32]. Reports in the lit-
erature show that treatment with the enzyme inhibitor allopur-
inol, increases ∙NO- dependent vasodilatation conﬁrming the role
for XO in vascular disease [96,98,104]. Overall, the increase in
purine levels and the immobilization-induced increase in XO sta-
bility and activity, support that XO bound to vascular cell GAGsFig. 2. Mitochondrial antioxidant systems. MnSOD catalyzes the dismutation of
O2∙–, leading to oxygen plus hydrogen peroxide (H2O2) formation. The latter is re-
duced to water by thiol- as well as selenol-dependent peroxidases, namely Prx3,
Prx5, GPx1 and GPx4, and in cardiomyocytes, also by catalase. According to kinetic
predictions, Prx3 is expected to be responsible for 490% of mitochondrial H2O2
decomposition. Alternatively, O2∙– can react with nitric oxide (∙NO) forming per-
oxynitrite anion (ONOO–). Its conjugated acid, peroxynitrous acid (ONOOH,
pKa¼6.8) is rapidly reduced to nitrite (NO2-) by GPx1 and Prx5, and probably by
Prx3 and GPx4, although the peroxynitrite reductase activity of the Prx3 and GPx4
is yet to be demonstrated. GPx4 catalyzes the reduction of phospholipid hydro-
peroxides (PLOOH) to the corresponding alcohols (PLOH). It is not clear whether
Prxs can also catalyze PLOOH reduction efﬁciently. PLOOH are hydrolyzed by
phospholipase A2 (PLA2) releasing fatty acid hydroperoxides (FAOOH), which are in
turn reduced to fatty acid alcohols (FAOH) by mitochondrial GPxs as well as Prx3
[267]. Although the ability of Prx5 to reduce FAOOH has not been investigated so
far, the enzyme has been reported to reduce other organic hydroperoxides [148].
The activity of mitochondrial GPxs and Prxs is sustained by the glutathione/glu-
tathione reductase and/or the thioredoxin 2/thioredoxin reductase 2 systems, both
relying on NADPH as ﬁnal electron donor.could be an important source of ROS in the vascular compartment,
affecting nitric oxide- and/or redox-dependent cell signaling re-
actions [96,98,104].5. Key antioxidant /detoxifying enzymes
Reactive oxygen and nitrogen species produced by the mi-
tochondria are implicated in the development of different meta-
bolic diseases [105–111]. Herein we detail the main antioxidants
involved in the detoxiﬁcation of reactive species (Fig. 2). Special
attention has been given to mitochondrial antioxidant enzymes,
since these play a key role in protecting the cell from most of the
oxidants formed in energy producing catabolic routes.
5.1. Superoxide detoxiﬁcation by MnSOD
Superoxide detoxiﬁcation is mediated mainly by SODs, a family
of enzymes that catalyze the dismutation of two molecules of O2∙
to H2O2 and O2. In mammals we can ﬁnd three forms of the en-
zyme, cytosolic copper zinc superoxide dismutase (Cu,ZnSOD or
SOD1) mitochondrial manganese superoxide dismutase (MnSOD
or SOD2) and extracellular Cu,ZnSOD (SOD3) [112]. In this review,
we will focus on MnSOD due to its key role detoxifying O2∙
formed in the mitochondria during aerobic catabolism of
biomolecules.
Mammalian MnSOD is a tetrameric enzyme with a redox active
manganese ion Mn2þ/Mn3þ in the active site [113]. The metal ion
participates in the catalysis mechanism where O2∙ dispropor-
tionate to oxygen and H2O2 in a ping- pong mechanism were O2∙
ﬁrst reduces de manganese ion and then a second O2∙ molecule
re-oxidizes the metal ion [114–115]. At high O2∙ concentrations
(45 fold enzyme concentration), kinetics become more compli-
cated and an inhibited complex between the reduced enzyme and
O2∙ is formed, (see review [112] for a full discussion).
MnSOD activity is regulated at multiple levels. Firstly gene
expression is controlled at the transcriptional level by several
transcription factors including Nuclear Factor-Kappa B (NF-κB),
Sp1, AP-1, AP-2, CCAAT-Enhancer-Binding Proteins (C/EBP), fore-
head transcription factor FOXO3a and p53 and at the epigenetic
level [116–118]. Its activity depends as well on the correct import
to mitochondria, the insertion of the manganese ion in the active
site and on several posttranslational modiﬁcations, including ni-
tration, phosphorylation and acetylation [119].
Nitration of highly conserved Tyr34 has been detected both in
vitro and in vivo under pathological conditions where oxidative
stress is implicated. This post translational modiﬁcation of a re-
sidue in the active site inhibits MnSOD activity [120–123], appar-
ently by electrostatically and sterically hindering the access of
O2∙ to the metal center [124]. Tyr34 nitration is mediated by
peroxynitrite, that reacts with the manganese ion in the active site
in a fast reaction [120].
Phosphorylation of Ser106 results in an increase enzymatic
activity and protein stability of human MnSOD. Cyclin B1/Cyclin
dependent kinase 1 and Cyclin D1/Cyclin dependent kinase 4 have
been shown to phosphorylate the enzyme in response to geno-
toxic stress [125–126]. Acetylation of MnSOD on conserved re-
sidues Lys122, Lys68, Lys53 and Lys89 has been observed in vivo
and is reported to decrease enzyme activity [127–129]. The me-
chanism by which acetylation interferes with catalysis has not
been elucidated, but it has been proposed that acetylation of
Lys122 alters the positive electric charge at the entrance to the
active site of the enzyme interfering with the electrostatic at-
traction of the O2∙ anion, resulting in lower catalytic rates [130].
Of all the mechanisms involved in the regulation of MnSOD,
acetylation is clearly one of the most important linking enzyme
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Enzymes responsible of MnSOD acetylation have not been un-
equivocally identiﬁed yet. GCN5L1 ((general control of amino acid
synthesis 5)-like 1) acetyltransferase and chemical acetylation
appear as possible candidates [131–132]. On the other hand, the
mitochondrial Sirtuin 3 (SIRT3), a mitochondrial NADþ dependent
protein deacetylase has been clearly identiﬁed as the enzyme re-
sponsible for MnSOD deacetylation [127–129] (Fig. 3).5.2. Peroxides and peroxynitrite detoxiﬁcation by mitochon-
drial peroxidases.
In mitochondria, H2O2, organic hydroperoxides and peroxyni-
trite are reduced by peroxidases from different families. These
include (a) cysteine-dependent peroxidases of the peroxiredoxin
(Prx) family (Prx3 and Prx5); (b) selenocysteine-dependent glu-
tathione peroxidases (GPx), GPx1 and GPx4; (c) heme-dependent
peroxidases, particularly catalase. Other heme-dependent perox-
idases that participate in hydroperoxide reduction in the mi-
tochondria but can also propagate damage due to compound I –
dependent reactivity with mitochondrial components (e.g. per-
oxidase activity of alternative conformations of cyt c3þ) are dis-
cussed brieﬂy below [133,134].
5.2.1. Peroxiredoxins
Prx are cysteine-dependent peroxidases that catalyze the re-
duction of different peroxides playing key roles in peroxide de-
toxiﬁcation as well as in redox signaling [135–138]. Among them
Prx3, that is exclusively located in mitochondria, has been esti-
mated to reduce 90% of H2O2 produced in the compartment, due
to its high reactivity (k¼2107 M–1 s–1) and abundance (60 mM)
[139]. Recent evidence suggest that Prx3 not only controls the
intramitochondrial levels of H2O2 but also plays a key regulatoryFig. 3. Sirtuin 3 coordinates fatty acid oxidation and superoxide detoxiﬁcation to
avoid oxidative stress. In fed conditions, acyl-CoA dehydrogenase (ACAD) and
manganese superoxide dismutase (MnSOD) are acetylated and their activity is low.
During starvation, Sirtuin 3 (SIRT3) levels increase. Upon deacetylation by SIRT3,
ACAD activity increases promoting fatty acid β-oxidation in the mitochondria. An
increase in fatty acid oxidation is accompanied by superoxide (O2∙) formation by
ACAD, electron transfer ﬂavoprotein (ETF), electron transferring ﬂavoprotein ubi-
quinone-oxidoreductase (ETF-QOR) and mitochondrial respiratory Complexes I and
III. However, SIRT3 also catalyzes the deacetylation of MnSOD, increasing its ac-
tivity, supporting the dismutation of O2∙ to O2 and hydrogen peroxide protecting
from oxidative stress. Deacetylation of FOXO3 by SIRT3 leads to an increase in
expression of MnSOD, mitochondrial peroxiredoxins and thioredoxin 2; and further
increases mitochondrial antioxidant capacity (not shown in the ﬁgure).role in the efﬂux of H2O2 to the cytosol [140].
Prx3 is probably also involved in peroxynitrite detoxiﬁcation, as
inferred from its protective role in an animal model of glutamate-
mediated exicitoxicity [141], although kinetic data on peroxyni-
trite reduction by Prx3 is still lacking. Tyrosine nitration of Prx3
has been identiﬁed in mitochondria from diabetic mice, yet the
site of nitration and the functional consequences of this mod-
iﬁcation remain to be established [142].
Prx3 is highly up regulated during adipogenesis, and its ex-
pression decreases in white adipose tissue of obese mice and hu-
mans. Prx3 KO mice are characterized by an increased suscept-
ibility to oxidative stress [143–145]. Prx3 KO mice are glucose
intolerant and insulin resistant, have higher body weight, in-
creased white fat content, hypertrophied adipocytes and adipo-
genic gene expression compared to WT mice. When lipid meta-
bolism gene expression is evaluated, adypocytes from Prx3 KO
mice showed increased gene expression of fatty acid synthase
(FAS), lipoprotein lipase and hormone sensitive lipase and de-
creased mRNA levels of carnitine palmitoyl transferase 1α, in-
volved in fatty acid oxidation. Moreover, Prx3 KO adypocytes show
changes in the expression of proteins involved in oxidative phos-
phorylation, mitochondrial biogenesis, fatty acid metabolism,
MnSOD and show an increase in oxidative stress markers, as well
as decreased mitochondrial potential [146]. The mechanism by
which Prx3 suppression leads to these profound metabolic al-
terations, particularly in the adipocyte, is still to be elucidated.
Mitochondrial Prx5, the other Prx present in human mi-
tochondria, is produced from a long alternative splicing form of
Prx5 that contains a mitochondrial targeting sequence that is
cleaved once translated to the mitochondria [147]. It is considered
to be a preferential mitochondrial target for peroxynitrite, due to
rapid reactivity (k¼7107 M–1 s–1 at pH 7.8, 25 °C) and con-
centrations (1–10 mM) [148–150]. It probably has a minor role in
reducing H2O2 compared with Prx3, since it has 100-fold lower
reactivity with this oxidant and lower protein concentration.
Nevertheless, overexpression of mitochondrial Prx5 was shown to
protect from H2O2-mediated mitochondrial DNA damage [151].
Recent data related to 1-methyl-4-phenylpyridinium (MPP)þ-in-
duced cell death suggested that mitochondrial Prx5 regulates
mitochondrial apoptotic pathways in a process that could involve
oxidative regulation of endoplasmic reticulum Ca2þ release [152,153].
5.2.2. Glutathione peroxidases
Glutathione peroxidases comprise another family of cysteine-
or selenocysteine- dependent peroxidases, that participate in the
detoxiﬁcation of different peroxides, redox signaling and control of
many cellular processes [154]. Human mitochondria express two
selenocysteine-dependent glutathione peroxidases, namely GPx1
and GPx4, which are expressed in other cellular compartments as
well. GPx1 rapidly reduces H2O2, peroxynitrite and free fatty acid
hydroperoxides at the expense of glutathione (GSH) [155]. How-
ever, its lower concentration (1-2 mM) compared with the Prxs
argues against a primary role of GPx1 in H2O2 or peroxynitrite
reduction in mitochondria under most physiological conditions
[139,150]. Gpx1 knockout mice did not have decreased lifespan,
but showed increased incidence of cataracts, hypertension, as well
as sensitivity to ischemia-reperfusion injury and to oxidative stress
[156]. Surprisingly, GPx1 over-expressing mice show a complex
diabetogenic phenotype, and although the cause is not clear, it
probably involves the disruption of the oxidative inactivation of
protein tyrosine phosphatases required for insulin-signaling
[157,158]. GPx1 overexpression also indicated that the enzyme
participates in redox-dependent cellular responses promoting
mitochondrial dysfunction, decreasing mitochondrial potential
and ATP production [159]. In turn, GPx4, phospholipid
Fig. 4. Oxidant regulation of glucose metabolism. Following uptake by glucose
transporters, glucose is phosphorylated by hexokinase to Glucose-6-phosphate
(Glucose-6P). Glucose-6P can enter the Glycolytic pathway to generate pyruvate,
ATP and NADH or it can enter the Pentose Phosphate Pathway yielding NADPH and
Ribose-5-phosphate (Ribose-5P). The level of reactive oxygen and nitrogen species,
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lipid hydroperoxides, which cannot be reduced by most of the
other peroxidases [160]. Its deletion leads to death in embryos and
even in adult mice [161,162]. However, heterozygous mice have a
mild increase in lifespan and reduced cancer incidence [163]. GPx4
is considered to protect mitochondria, preventing the loss of
membrane potential under oxidative stress conditions [164]. Glu-
tathione peroxidases, and particularly Gpx4, inhibit the production
of lipid mediators by different mechanisms, including the inhibi-
tion of different lipoxygenases [165,166].
5.2.3. Catalase
Catalase is an antioxidant enzyme that catalyzes de dismuta-
tion of H2O2 to O2 and water (H2O) [167]. In most tissues its ex-
pressed in peroxisomes, but it is also present in the mitochondria
of mammalian cardiomyocytes [168]. To note, catalase content and
activity in cardiomyocyte mitochondria signiﬁcantly increase
during high fat feeding [169], probably reﬂecting increased mi-
tochondrial H2O2 production from fat metabolism. The lifespan of
mice overexpressing catalase in the mitochondria is increased
[170], and the enzyme is considered to prevent mitochondrial
dysfunction and resistance to insulin [171].such as hydrogen peroxide (H2O2) and peroxynitrous acid (ONOOH) inﬂuences the
fate of glucose. Reactive species inhibit glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) and increase the activity of glucose-6-phosphate dehy-
drogenase (G6PDH); shifting glucose from an energy producing pathway to NADPH
formation for antioxidant systems.5.3. Mitochondrial thioredoxin/thioredoxin reductase and
glutaredoxin systems
Thioredoxin 2 (Trx) is the main reducing substrate for mi-
tochondrial peroxiredoxins. It is reduced by thioredoxin reductase
2 at NADPH expense. Besides, both thioredoxin 1 (cytosolic) and
thioredoxin 2 (mitochondrial) form complexes with the redox-
sensitive serine/threonine kinase apoptosis signal-regulating ki-
nase 1 (AKS1). Under oxidative stress conditions, Trx is oxidized
and dissociates from the Trx-ASK1 complex, leading to ASK1 ac-
tivation and induction of mitochondrial-dependent apoptotic cell
death [172]. In plants, the activity of two TCA enzymes, namely
succinate dehydrogenase and fumarase, as well as the associated
cytosolic enzyme, ATP citrate lyase, are regulated by Trx [173].
Mitochondrial glutaredoxin 2 plus GSH can also act as reducing
substrates for Prx3 [174]. Furthermore, monothiol glutaredoxins
have been proposed to play a crucial role in iron-sulfur protein
biogenesis mediating the transfer of 2Fe2S clusters from scaffold
proteins to target apo proteins [175].6. Key oxidant targets in metabolic routes
6.1. Glyceraldehyde- 3-phosphate dehydrogenase
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a tetra-
mer consisting of four identical catalytically active subunits, is a
key glycolytic enzyme that reversibly catalyzes the oxidation and
phosphorylation of glyceraldehyde-3-phosphate (GAP). The cata-
lytic reaction involves the formation of a hemithioacetal between
GAP and the catalytic Cys149, thus rendering GAPDH highly sen-
sitive to inactivation by oxidants [58,176,177] and lipid oxidation
products [58,178].
It has been shown that GAPDH can be inhibited by ∙NO through
the formation of a S-nitrosothiol intermediate. Besides ∙NO can
induce translocation of GAPDH to speciﬁc cellular microenviron-
ments inﬂuencing its role in intermediary metabolism and apop-
totic signaling [179–181]. GAPDH is sensitive to peroxynitrite and
H2O2 that react with Cys149 inducing enzyme inhibition through
sulfenic acid formation [176,182,183] (Fig. 4). In a recent report,
the molecular basis of the high sensitivity of the catalytic cysteineresidue to H2O2 was unraveled, evidencing the existence of a
proton shuttling pathway that stabilizes the transition state fa-
voring sulfenic acid formation and hydroxyl anion departure [177].
The impact of these reactions on glucose metabolism is discussed
below.
Finally, GAPDH Cys149 and other nucleophilic Cys and His re-
sidues can be modiﬁed by nitroalkenes, inactivating the enzyme
[58]. Some reports show that besides from its known role as an
intermediary metabolism enzyme, GAPDH can participate in cell
signaling, DNA repair, transcriptional regulation of genes, mem-
brane fusion, tubulin bundling, and apoptotic signaling [182–184].
Importantly, nitroalkylation of GAPDH promotes its migration to
cell membranes and might be responsible for changes in the
subcellular distribution and function of GAPDH in
certain situations [58].
6.2. Tricarboxylic acid cycle enzymes
The TCA cycle, also known as citric acid cycle or Krebs cycle, is a
hub in metabolism where degradative pathways converge and
precursors for anabolic pathways are synthesized. In the TCA cycle,
acetyl-CoA formed during the catabolism of carbohydrates, ami-
noacids and fatty acids is oxidized to carbon dioxide. The energy
released in these oxidative reactions is conserved in reduced
electron carriers, NADH and FADH2, which are utilized to generate
ATP by oxidative phosphorylation in the inner mitochondrial
membrane. The intermediates of the cycle are also used in bio-
synthetic reactions of glucose, aminoacids, lipids, heme, and other
biomolecules. The TCA cycle is tightly regulated in coordination
with other mitochondrial pathways. Two enzymes from the Krebs
cycle appear as the main targets of mitochondrial oxidants: aco-
nitase and α-ketoglutarate dehydrogenase (Fig. 1).
Mitochondrial aconitase catalyzes the reversible isomerization
of citrate to isocitrate via cis-aconitate. Aconitase contains a non-
redox [4Fe–4S] prosthetic group in which one of the iron ions (Feα)
is not ligated to a protein residue and thus can bind to hydroxyl
groups of substrates or water [185]. Superoxide, peroxynitrite and
C. Quijano et al. / Redox Biology 8 (2016) 28–42 35CO3∙– rapidly react with the FeS cluster, yielding a catalytically
inactive [3Fe–4S]-protein [186,187]. The aconitase iron–sulfur
cluster has a net oxidation state of þ2; the local positive charge of
the Fe is exposed attracting mitochondrial anionic oxidants. Su-
peroxide reaction with aconitase iron–sulfur cluster is very selec-
tive and fast (k107 M–1 s–1) and leads to the release of the Feα
reactivation of mitochondrial aconitase is achieved by re-
incorporation of Fe2þ and is favored by reductants such as GSH.
The ratio between [4Fe-4S]-aconitase and [3Fe–4S]-aconitase has
been used to determine the steady-state concentration of O2∙ in
cells [22,186]. Hydrogen peroxide inactivates aconitase by the
same mechanism as O2∙ , but with lower efﬁciency [188]. In
addition, ∙NO interacts directly and reversibly with aconitase FeS
cluster, while sustained ∙NO production slowly promotes an irre-
versible disassembly of the FeS cluster [187,189].
The presence of an extremely O2∙-sensitive enzyme within the
mitochondrial matrix led to the speculation that mitochondrial
aconitase may provide a redox control mechanism of the TCA cycle,
the ETC and O2∙ production by mitochondria [190]. With a meta-
bolic control approach using isolated mammalian mitochondria our
laboratory showed that, inhibition of aconitase could impact on
mitochondrial metabolism by diminishing the entry of reducing
equivalents to the ETC, decreasing mitochondrial membrane poten-
tial and the diminishing the rate of O2∙ and H2O2 production [191].
Besides from the oxidation and disruption of the FeS cluster of
aconitase, other redox post-translational modiﬁcations of this
enzyme have been found. Proteomic analysis of mitochondria from
animal models of sepsis, diabetes and aging revealed aconitase
inactivation and nitration in vivo [142,192–195]. Additionally,
glutathionylation, carbonylation and S-nitrosylation have been
detected in mitochondrial aconitase [196,197] but have not been
shown to affect the catalytical activity of the enzyme and their
biological signiﬁcance is still unclear.
Further, aconitase activity seems to be regulated by phos-
phorylation. In particular, phosphorylated aconitase was found in
skeletal muscle of human and in hearts from type 1 diabetic rats
[198,199]. Exercising accompanied aconitase dephosphorylation
and augmented its catalytic activity towards isocitrate formation.
While protein kinase C phosphorylation of mitochondrial aconi-
tase in diabetic rat hearts was associated with an increase in its
reverse activity, leading to citrate formation [200]. This mechan-
ism together with redox inhibition of aconitase activity could in-
hibit the TCA cycle leading to the accumulation of upstream me-
tabolites, decreased electron transport and lower O2∙ production
by the ETC.
Aconitase activity increases upon acetylation, which increases
the enzyme’s maximal velocity (Vmax). SIRT3 was shown to dea-
cetylate several lysines in aconitase, reversing the activation of the
enzyme. Aconitase acetylation has been observed in vitro and
in vivo in the hearts of mice fed a high-fat diet and may play a role
sensing nutrient availability and regulating fatty acid oxidation
[201].
Modulation of the TCA cycle by aconitase can operate as part of
a coordinated mitochondrial redox regulation network. Using
proteomic techniques, several thiol containing mitochondrial
proteins that react with low physiological levels of H2O2 were
identiﬁed [202]. Among them, pyruvate dehydrogenase kinase 2
(PDHK2), a major regulator of pyruvate dehydrogenase complex
(PDH), can be inactivated by oxidation of Cys residues 45 and 392
[202,203]. PDHK2 inactivation results in a decrease in PDH phos-
phorylation and an increase in PDH activity that subsequently
increases acetyl-CoA formation [203]. Therefore, in the face of
oxidative stress, formation of acetyl-CoA would increase but aco-
nitase inhibition would decrease TCA ﬂux, shifting the balance
from carbohydrate catabolism and to fatty acid synthesis.
Alpha-ketoglutarate dehydrogenase is a TCA cycle enzyme thatcatalyzes the non-equilibrium reaction converting α-ketogluta-
rate, coenzyme A and NADþ to succinyl-CoA, NADH and CO2. α-
KGDH is a complex enzyme consisting of multiple copies of three
subunits, a thiamine pyrophosphate-dependent dehydrogenase
(E1), dihydrolipoamide succinyltransferase (E2) and a ﬂavoprotein,
dihydrolipoamide dehydrogenase (E3) [204,205]. α-Ketoglutarate
dehydrogenase is considered to be both a target and a source of
oxidant species [204]. As a target, α-KGDH was found to be sen-
sitive to peroxynitrite and H2O2-dependent inactivation [206–
209]. While the intimate mechanism by which H2O2 inactivates α-
KGDH is unresolved, it probably involves the oxidation of sulfhy-
dryl groups present in one or more of the three subunits. In fact, a
recent report indicates that H2O2 can inactivate dihydrolipoamide
dehydrogenase both in α-KGDH and PDH [210]. Peroxynitrite in
turn promotes speciﬁc tyrosine nitration, which results in enzyme
inactivation [209]. Inactivation of α-KGDH has been reported in
several neurodegenerative disorders. [204,205]. α-Ketoglutarate
dehydrogenase is a primary control site of the TCA cycle and is
regulated by the ATP/ADP ratio, the NADH/NADþ ratio, substrate
availability and calcium concentration in mitochondria [211,212].
Therefore impaired α-KGDH activity due to oxidative stress will
limit TCA cycle activity (i.e. NADH production).
A study with brain synaptosomes showed that aconitase was
the principal enzyme inhibited at low H2O2 concentrations. In this
condition, with aconitase blocked, the Krebs cycle could be fueled
by glutamate and therefore NADH generation was not impaired.
However, at higher H2O2 concentrations (Z 100 mM) inhibition of
α-KGDH limited NADH availability for respiration [208]. Therefore,
under conditions where pyruvate or acetyl-CoA are the main
substrate of the TCA cycle, oxidant-mediated inhibition of aconi-
tase would affect NADH formation. Yet, in conditions or tissues
where glutamate could fuel the TCA cycle, NADH production
would be maintained until mitochondrial oxidants inhibited α-
KGDH activity, and only then would oxidant stress severely impair
mitochondrial bioenergetics.
Interestingly, aconitase and α-KGDH are associated with the
mitochondrial nucleoid and may be involved in mitochondrial
DNA stabilization [213–215]. The signals that modulate these in-
teractions are to still to be determined but probably involve oxi-
dative modiﬁcations of the proteins.
6.3. Succinate dehydrogenase
Former reports from our group showed that physiologically
relevant concentrations of peroxynitrite inactivate mitochondrial
ETC through preferential inactivation of succinate dehydrogenase
(SDH), leading to a decrease in O2 consumption [6,216].
6.4. ATP synthase and creatine kinase
Peroxynitrite inactivates mitochondrial ATP synthase (ATPase;
Complex V) and results in reduced ATP synthesis in mitochondria
[216,217]. Peroxynitrite inactivation of the enzyme is accompanied
of tyrosine nitration [216,217]. Critical Tyr residues are found in
ATP synthase, but it remains to be determined if nitration of these
residues is responsible of Complex V inactivation. Creatine kinase
is also inhibited by peroxynitrite in a fast reaction involving thiol
oxidation (k¼8.85105 M1 s1) [218].
6.5. Cytochrome c
Cytochrome c (cyt c) is a peripheral membrane protein of the
inner mitochondrial membrane with a covalently attached heme
group.
In mitochondria, cyt c has different activities depending of its
interaction with the mitochondrial inner membrane. Almost 85%
C. Quijano et al. / Redox Biology 8 (2016) 28–4236of cyt c is loosely bound to the membrane while the remaining is
tightly bound through its interactions with cardiolipin [219,220].
While the loosely bound cyt c participates in electron transport,
membrane-bound cyt c has peroxidase activity and can reduce
H2O2 formed in the inter-membrane space preventing its diffusion
to the cytosol [219–224]. However, cyt c peroxidase activity can
also lead to the formation of hydroxy and hydroperoxy derivatives
of the mitochondrial lipid cardiolipin, a critical event in the release
of cyt c and induction of apoptosis [219,220].
Interaction of cyt c with anionic phospholipids and/or reactions
with oxidants, such as peroxynitrite, increases the peroxidase ac-
tivity of cyt c [219,220,224]. In fact, biologically relevant con-
centrations of peroxynitrite have been shown to promote cyt c
release from intact mitochondria [219,224–226]. It has been pro-
posed that ∙NO may regulate the peroxidase activity of cyt c
through reduction of highly oxidized states of the heme [224,227].
Peroxynitrite reaction with cyt c results in tyrosine nitration
[225]. This posttranslational modiﬁcation affects cyt c redox
properties impairing its electron transport ability in the mi-
tochondrial respiratory chain. Indeed, basal respiration cannot be
recovered when cyt c-depleted mitochondria are reconstituted
with peroxynitrite- treated cyt c [224,226].
6.6. Cytochrome c oxidase
The most sensitive target of ∙NO in mitochondria is the heme
group in cytochrome c oxidase. The ∙NO- cytochrome c oxidase
interaction is involved in the maintenance of O2 gradients within
tissues, through the modulation of actively respiring mitochon-
dria. [228–230]. High levels of ∙NO can affect ATP synthesis and
can promote the generation of O2∙ by the ETC [228–230]. In
contrast to ∙NO, peroxynitrite is unable to inhibit cytochrome c
oxidase, since Complex IV is highly resistant to oxidative damage
[230–232].
6.7. Fatty acids
Mitochondria are the place where most of the oxidation of fatty
acids (β-oxidation) to obtain energy occurs. As explained above,
increased ROS and RNS levels in mitochondria can lead to the
formation of nitro-fatty acids [48,62]. The presence of the nitro
group (NO2) affects the catabolism of the fatty acid. A study of the
metabolic fate of NO2-OA (NO2-18:1 Δ9) injected to mice showed
the desaturation of the double bond where the NO2 was bonded
was followed by the formation of β-oxidation products. β-oxida-
tion products of 16, 14 and 12 carbons containing the NO2 group
were detected suggesting that β-oxidation stops at the carbon
with the attached NO2 group [49,233].7. Peroxisome proliferator-activated receptor-γ (PPAR-γ)
Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) is a
member of the nuclear hormone receptor superfamily of ligand-
activated transcription factors that regulate genes involved mainly
in lipid and glucose metabolism [234,235]. Different ligands acti-
vate the receptor including antidiabetic thiazolidinedione (TZD)
drugs or fatty acids derived products such as eicosanoids or 15D-
PGJ2, [234,235]. It is now well demonstrated that nitroalkenes are
potent activators of PPAR-γ. For example, NO2-LA and NO2-OA
exert many of their cell signaling actions via ligation and activation
of PPARγ [55,236]. Activated PPARγ modulates the expression of
metabolic and cellular differentiation genes (e.g. genes related to
lipid trafﬁcking, cell proliferation and inﬂammatory signaling in
the vasculature) and regulates inﬂammatory responses [237–239].
Importantly, nitroalkenes exert their actions at lower doses (lowmicromolar concentrations) than other endogenous ligands for
PPARγ [236]. The biological relevance of the regulation of PPARγ
by nitroalkenes was established when NO2-OA was administrated
to ob/ob mice and was seen to modulate insulin and glucose levels
without inducing adverse side effects [234].8. Remarkable examples of interplay between oxidant species
and energy metabolism
8.1. Sirtuin 3 coordinates catabolic reactions with antioxidant sys-
tems in mitochondria
Sirtuin 3 (SIRT3) is a NAD dependent deacetylase of protein
lysine residues. Its levels increase during fasting and caloric re-
striction and mediate the switch from glucose to fatty acid utili-
zation as a source of energy [240], by catalyzing the deacetylation
and activation of LCAD [241]. Increased fatty acid oxidation would
be coupled to an increase in O2∙ formation, yet SIRT3 also pro-
motes the activation of MnSOD by deacetylation [127–129] prob-
ably preventing the accumulation of O2∙ and thus oxidative stress
in this setting (Fig. 3). SIRT3 also catalyzes the deacetylation and
activation of Isocitrate dehydrogenase 2 [242], a TCA cycle enzyme
that maintains the NADPH pool required by GSH reductase, further
protecting the cell from oxidative damage. Finally, SIRT3 has been
demonstrated to catalyze the deacetylation of the transcriptional
regulator FOXO3, leading to FOXO3 stabilization. Consequently,
there is an increased expression of not only MnSOD but also other
mitochondrial antioxidant systems under its control, including
Prx3 and thioredoxin 2 [243].
8.2. Shifting glucose to the pentose phosphate pathway for oxidant
detoxiﬁcation
Glucose enters the cell through glucose transporters and, is
then phosphorylated to glucose-6-phosphate. Glucose-6-phos-
phate is a substrate of the glycolytic pathway, that produces ATP,
NADH and pyruvate, and of the pentose phosphate pathway (PPP)
rendering ribose-5-phosphate and NADPH. The ability of the cell
to efﬁciently channel these metabolites into different pathways
depending on its needs is key to survival [244]. In the face of
oxidative stress, glucose utilization must be shifted from the gly-
colytic pathway to the PPP to produce NADPH, in order to maintain
the antioxidants glutathione and thioredoxin in reduced states
[245,246].
An important sensor of oxidant formation, that appears to play
a role shifting glucose utilization to the PPP, is GAPDH. As men-
tioned above, GAPDH is a glycolytic enzyme, sensitive to oxidants,
since the cysteine residue in the active site of the enzyme is oxi-
dized by H2O2 and peroxynitrite with higher reaction rates than
most thiols other than peroxidatic thiols [176,247,248]. This critical
cysteine oxidation allows yeast to reroute glucose from glycolysis
to the PPP favoring NADPH formation, and cell survival in oxida-
tive stress conditions [177] (Fig. 4). The glycolytic enzyme pyruvate
kinase M2 is sensitive to oxidants as well. Oxidation of Cys358
inﬂuences enzyme activity and seems to contribute to glucose
rerouting to the PPP [249].
While GAPDH is inhibited by oxidants glucose -6-phosphate
dehydrogenase (G6PD), the enzyme that catalyzes the ﬁrst rate-
limiting step in the PPP, is activated by hydrogen peroxide [250]
and by peroxynitrite [251]. Activation of G6PD up regulates the
PPP and increases NAPDH levels and the ability of cells to re-
generate GSH from GSSG [251]. Thus, an increase in oxidant for-
mation is accompanied of activation and inhibition of key reg-
ulatory enzymes that result in a shift from ATP to NADPH forma-
tion, increasing the cells antioxidant capacities (Fig. 4).
C. Quijano et al. / Redox Biology 8 (2016) 28–42 37A recent metabolomic study shows that rerouting of metabo-
lites to the PPP is in fact activated immediately after exposure to
H2O2 and precedes the accumulation of glycolytic intermediates
due to GAPDH inhibition; instead, they propose that NADPH al-
losteric regulation of G6PD plays a key role in this early response
to oxidative stress [246].
Herrero-Mendez and colleagues present another striking ex-
ample of metabolic reprogramming showing that bioenergetics
and antioxidant status of neurons is controlled by continuous
degradation of enzyme 6‐phosphofructo‐2‐kinase/ fructose‐2, 6‐
bisphosphatase‐3 (PFKB3) by E3 ubiquitin ligase, anaphase‐pro-
moting complex/cyclosome (APC/C)–Cdh1 [252]. PFKB3 catalyzes
the synthesis of fructose‐2,6‐bisphosphate (F2,6P2), a potent ac-
tivator of 6‐phosphofructo‐1‐kinase the principal regulator of the
glycolytic pathway. In neurons, continuous degradation of PFKB3
in the proteasome assures a low ﬂux of glucose through the gly-
colytic pathway allowing the neurons to use glucose in the PPP.
Interfering with PFKB3 degradation or overexpression of PFK3B
led to oxidative stress and apoptotic cell death [252]. In fact
neuron exicitoxicity cell death promoted by activation of N-me-
thyl-D-aspartate subtype of glutamate receptors (NMDAR), ap-
pears to involve not only an increase nitric oxide production by
nitric oxide synthase 1 (NOS1) but also a stabilization of PFKB3,
that results in GSH oxidation triggering oxidative damage and cell
death [253].9. Concluding remarks and future directions
Reactive oxygen species are continuously being formed during
the catabolism of biomolecules. Superoxide and H2O2 are produced
during electron transfer reactions in several metabolic pathways
and can lead to the formation of highly oxidizing species such as
peroxynitrite and lipid derived electrophiles. Reactive species are
detoxiﬁed by a battery of antioxidant enzymes, but react as well
with several cellular components. In this review, we have tried to
identify key targets of oxidant species in metabolic routes and
discussed the impact of these reactions on overall metabolic ﬂux.
We have also reviewed examples of coordinate regulation between
antioxidant and energy producing pathways that help to avoid
oxidative stress. In this setting reactive species, appear to play a role
as signaling molecules capable of regulating metabolic ﬂux in re-
sponse to changes in the redox status of the cell.
Among future directions of research in the ﬁeld, we ﬁnd the
role of the mitochondria quality control systems in maintaining
bioenergetic efﬁciency and controlling oxidant formation by the
ETC. Autophagy is the main process involved in mitochondrial
turnover and removal of damaged mitochondria and impaired
autophagy is implicated in many pathological conditions, includ-
ing neurological disorders, inﬂammatory bowel disease, diabetes,
aging, and cancer [254]. Defects in components of the mitochon-
drial autophagy (mitophagy) machinery, and impaired mitophagy
result in an increase in mitochondrial ROS formation [255,256], yet
sites of oxidant formation have not been identiﬁed. Moreover,
mitochondrial ROS appear to play signaling roles, promoting au-
tophagy during cell starvation or metabolic stress [257,258], evi-
dencing a complex regulatory axis still to be fully characterized.
Fusion and ﬁssion processes governing mitochondrial morphology
and function [259] are affected by ROS levels in several cell and
animal models; and mounting evidence suggests that cellular and
mitochondrial redox homeostasis are linked to mitochondrial dy-
namics (recently revised in [260]). These events require further
characterization at the molecular level and appear as a promising
area of research.
Reactions of oxidants with master regulators of cellular energy
state, such as AMPK, mTOR and Akt, are probably essential inencompassing metabolic pathways and redox status. Although ROS
are known to impact in the signaling pathways governed by these
kinases [261–264], few of the reactions have been fully character-
ized (e.g. AMPK oxidation and activation by H2O2 [265]), and are
still unexplored. Biochemical identiﬁcation of oxidative post-
translational modiﬁcations in target residues, and kinetic constants
for the reactions of cell energy sensors with different oxidant spe-
cies, will surely contribute to the advancement of the ﬁeld.Sources of funding
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